Computational Identification of Possible Allosteric Sites and Modulators of the SARS-CoV-2 Main Protease

被引:8
|
作者
DasGupta, Debarati [1 ]
Chan, Wallace K. B. [2 ]
Carlson, Heather A. [1 ]
机构
[1] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA
基金
美国国家卫生研究院;
关键词
MOLECULAR-DYNAMICS SIMULATIONS; INHIBITORS; PARAMETERS; DOCKING; SERVER;
D O I
10.1021/acs.jcim.1c01223
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In this study, we target the main protease (M-Pro) of the SARS-CoV-2 virus as it is a crucial enzyme for viral replication. Herein, we report three plausible allosteric sites on M-Pro that can expand structure-based drug discovery efforts for new M-Pro inhibitors. To find these sites, we used mixed-solvent molecular dynamics (MixMD) simulations, an efficient computational protocol that finds binding hotspots through mapping the surface of unbound proteins with 5% cosolvents in water. We have used normal mode analysis to support our claim of allosteric control for these sites. Further, we have performed virtual screening against the sites with 361 hits from M(Pro )screenings available through the National Center for Advancing Translational Sciences (NCATS). We have identified the NCATS inhibitors that bind to the remote sites better than the active site of M-Pro, and we propose these molecules may be allosteric regulators of the system. After identifying our sites, new X-ray crystal structures were released that show fragment molecules in the sites we found, supporting the notion that these sites are accurate and druggable.
引用
收藏
页码:618 / 626
页数:9
相关论文
共 50 条
  • [41] Factual insights of the allosteric inhibition mechanism of SARS-CoV-2 main protease by quercetin: an in silico analysis
    Shalja Verma
    Anand Kumar Pandey
    3 Biotech, 2021, 11
  • [42] Factual insights of the allosteric inhibition mechanism of SARS-CoV-2 main protease by quercetin: an in silico analysis
    Verma, Shalja
    Pandey, Anand Kumar
    3 BIOTECH, 2021, 11 (02)
  • [43] Structural biology of SARS-CoV-1/SARS-CoV-2 main protease
    Gao, Yunyun
    Kaub, Johannes
    Santoni, Gianluca
    Pearce, Nicholas
    Thorn, Andrea
    CRYSTALLOGRAPHY REVIEWS, 2023, 29 (02) : 76 - 101
  • [44] Allosteric Inhibition of the SARS-CoV-2 Main Protease: Insights from Mass Spectrometry Based Assays
    El-Baba, Tarick J.
    Lutomski, Corinne A.
    Kantsadi, Anastassia L.
    Malla, Tika R.
    John, Tobias
    Mikhailov, Victor
    Bolla, Jani R.
    Schofield, Christopher J.
    Zitzmann, Nicole
    Vakonakis, Ioannis
    Robinson, Carol V.
    Advanced Materials, 2020, 132 (52) : 23750 - 23754
  • [45] Allosteric Inhibition of the SARS-CoV-2 Main Protease: Insights from Mass Spectrometry Based Assays
    El-Baba, Tarick J.
    Lutomski, Corinne A.
    Kantsadi, Anastassia L.
    Malla, Tika R.
    John, Tobias
    Mikhailov, Victor
    Bolla, Jani R.
    Schofield, Christopher J.
    Zitzmann, Nicole
    Vakonakis, Ioannis
    Robinson, Carol V.
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2020, 59 (52) : 23544 - 23548
  • [46] Identification of repurposing therapeutics toward SARS-CoV-2 main protease by virtual screening
    Sanachai, Kamonpan
    Somboon, Tuanjai
    Wilasluck, Patcharin
    Deetanya, Peerapon
    Wolschann, Peter
    Langer, Thierry
    Lee, Vannajan Sanghiran
    Wangkanont, Kittikhun
    Rungrotmongkol, Thanyada
    Hannongbua, Supot
    PLOS ONE, 2022, 17 (06):
  • [47] Structure-based identification of potential SARS-CoV-2 main protease inhibitors
    Khan, Shama
    Fakhar, Zeynab
    Hussain, Afzal
    Ahmad, Aijaz
    Jairajpuri, Deeba Shamim
    Alajmi, Mohamed F.
    Hassan, Md. Imtaiyaz
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (08): : 3595 - 3608
  • [48] Drug repurposing and computational modeling for discovery of inhibitors of the main protease (Mpro) of SARS-CoV-2
    Silva, Jose Rogerio A.
    Kruger, Hendrik G.
    Molfetta, Fabio A.
    RSC ADVANCES, 2021, 11 (38) : 23450 - 23458
  • [49] Computational studies indicated the effectiveness of human metabolites against SARS-Cov-2 main protease
    Roy, Rajarshi
    Sk, Md Fulbabu
    Tanwar, Omprakash
    Kar, Parimal
    MOLECULAR DIVERSITY, 2023, 27 (04) : 1587 - 1602
  • [50] Interactions between main protease of SARS-CoV-2 and testosterone or progesterone using computational approach
    Vishvakarma, Vijay Kumar
    Pal, Shweta
    Singh, Prashant
    Bahadur, Indra
    JOURNAL OF MOLECULAR STRUCTURE, 2022, 1251